Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Movitex is a line of dietary supplements developed by Laboratorios Combix, specifically formulated to support joint health and the musculoskeletal system. The product contains a synergistic blend of ingredients including glucosamine sulfate, chondroitin sulfate, hyaluronic acid, collagen, and vitamin C, which provide the necessary building blocks for cartilage repair and joint lubrication. Additionally, it incorporates harpagofito (devil's claw), a botanical extract known for its anti-inflammatory properties. Movitex is intended to address joint pain, inflammation, and mobility issues in the locomotor system. It is available in oral forms such as capsules and powder and is formulated to be free of gluten, lactose, and sucrose.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Movitex.